Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type.
Ontology highlight
ABSTRACT: Breast cancer is a heterogeneous disease with different molecular subtypes. Breast cancer is the second leading cause of mortality in woman due to rapid metastasis and disease recurrence. Precision medicine remains an essential source to lower the off-target toxicities of chemotherapeutic agents and maximize the patient benefits. This is a crucial approach for a more effective treatment and prevention of disease. Precision-medicine methods are based on the selection of suitable biomarkers to envision the effectiveness of targeted therapy in a specific group of patients. Several druggable mutations have been identified in breast cancer patients. Current improvements in omics technologies have focused on more precise strategies for precision therapy. The development of next-generation sequen
SUBMITTER: Subhan MA
PROVIDER: S-EPMC10137302 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA